Pneumonia - treatment
Application of metabolomics in viral pneumonia treatment with traditional Chinese medicine
... viral pneumonia (Table ...in treatment of H1N1 pneu- ...the treatment of pneumonia and asthma ...JOL treatment, compared with the model group, glutamine and glutamic acid were ...
11
A retrospective observational study on the efficacy of colistin by inhalation as compared to parenteral administration for the treatment of nosocomial pneumonia associated with multidrug resistant Pseudomonas aeruginosa
... for treatment of nosocomial pneumonia caused by MDR gramnegative bacteria ...intravenous treatment with colistin or other antimicrobial agents [20] (Table ...parenteral treatment, had a ...
8
Clinical utility of telavancin for treatment of hospital-acquired pneumonia: focus on non-ventilator-associated pneumonia
... Hospital-acquired pneumonia (HAP) is the most common health care-associated infection contributing to ...ventilator-associated pneumonia (VAP) and non-ventilator- associated pneumonia ...available, ...
7
Telavancin for the treatment of nosocomial pneumonia caused by methicillin-resistant <em>Staphylococcus aureus</em> (MRSA)
... with pneumonia due to MRSA with or without other patho- gens was also similar between the two treatment ...However, treatment with telavancin was associated with higher cure rates in patients with ...
7
Lung inflammatory pattern and antibiotic treatment in pneumonia
... First, the absence of BAL fluid samples in the CAP control group as, for ethical reasons, we did not perform a bronchoscopy in patients with adequate response. There are few human studies that report compartmental ...
8
Linezolid for the treatment of hospital-acquired pneumonia in a Chinese tertiary hospital
... The low response rate reported in this analysis potentially reflects the empirical administration of linezolid and vancomy- cin in this study. In general, HAP treatment was not guided by identification of a ...
6
Intravenous Versus Oral Antibiotics for Postdischarge Treatment of Complicated Pneumonia
... necrotizing pneumonia. These variables may be associated with both treatment decisions (eg, need for pleural drainage) and ...of treatment failures ...
11
Treatment of mycophenolate-resistant immune-related organizing pneumonia with infliximab
... steroid treatment of 68 days (range, 20 to 154 ...combination treatment with cyclophosphamide and infliximab was ...infliximab treatment can be seen in Table ...organizing pneumonia was not ...
7
Potential role of tigecycline in the treatment of community-acquired bacterial pneumonia
... CABP (confirmed by chest radiograph and at least two of the following: symptoms consistent with a bacterial respira- tory infection, leukocytosis, or hypoxemia) who required IV antibiotics were included. Those who failed ...
10
Asthma and treatment with inhaled corticosteroids: associations with hospitalisations with pneumonia
... with pneumonia is a strength as this makes the risk of misdiagnosis smaller as radiog- raphy is a standard procedure in investigation of pneu- monia in inpatient care in Sweden ...and pneumonia in ...
8
Ceftobiprole for the treatment of pneumonia: a European perspective
... Abstract: Ceftobiprole, a new broad spectrum, parenteral cephalosporin, exhibits potent in vitro activity against a number of Gram-positive pathogens, including methicillin-resistant Staphylo- coccus aureus and ...
8
Original Article Analysis of clinical efficacy and prognostic factors of vidarabine in combination with human immunoglobulin in the treatment of children with adenovirus pneumonia
... the treatment of children with adenovirus ...After treatment, the improvement of clinical symptoms (disappearance time of fe- ver, cough and moist rales; hospital stay) and changes of laboratory parameters ...
8
Antibacterial treatment of aspiration pneumonia in older people: a systematic review
... clindamycin in overdose patients with the evidence of aspira- tion pneumonia admitted to ICU with the majority requir- ing mechanical ventilation. The average age of patients in this study was approximately 32 ...
13
Validation of sputum Gram stain for treatment of community acquired pneumonia and healthcare associated pneumonia: a prospective observational study
... with pneumonia who were hospitalized at Okinawa Chubu Hospital (a 550-bed acute care hos- pital in Okinawa, Japan) from August 2010 to July ...2012. Pneumonia was defined as a new infiltrate on chest X-ray ...
8
PNEUMOCYSTIS CARINII PNEUMONIA AND ALTERED HOST RESISTANCE: TREATMENT OF ONE PATIENT WITH PENTAMIDINE ISETHIONATE
... TREATMENT OF ONE PATIENT WITH PENTAMIDINE ISETHIONATE PNEUMONIA AND ALTERED HOST RESISTANCE:. PNEUMOCYSTIS CARINII[r] ...
12
Characteristics of an ideal nebulized antibiotic for the treatment of pneumonia in the intubated patient
... Effective treatment of bacterial pneumonia requires the concentration of the antibiotic in the lung to exceed the minimum inhibitory concentration (MIC) of the infect- ing ...
8
Treatment of Chlamydial Pneumonia of Infancy
... mycin ethyl succinate, 40 mg/kg/day, for approximately 14 days to treat 32 patients with chlamydial pneumonia of infancy, and observed them for nasopharyngeal shedding of.. C trachomatis[r] ...
8
Treatment of Mycoplasma Pneumonia: A Systematic Review
... compared treatment regimens with and without spectrum of activity against ...pneumoniae treatment in CA-LRTI secondary to ...favoring treatment was not signi fi cantly different and demonstrated signi ...
12
Constructing Empirical Likelihood Confidence Intervals for Medical Cost Data with Censored Observations
... Variable Description Heart attack treatment Heart failure treatment Pneumonia treatment Surgical infection prevention Capital cost-to-charge ratio Operating cost-to-charge ratio Hospital[r] ...
113
Streptococcus pneumoniae in patients with community- acquired pneumonia in Khartoum State: A cross-sectional Study
... CAP most frequently affects individuals at extremes of age and those with any type of parallel illness (Torres et al., 2013). Pneumococcal community-acquired pneumonia most commonly presents as non-bacteremic ...
12